Iolyx Therapeutics
- Biotech or pharma, therapeutic R&D
Iolyx is an Immuno-Ophthalmology small molecule therapeutics company focused on transforming the standard of care for inflammatory and autoimmune diseases impacting the front and back of the eye. We recently completed a randomized Ph2 trial with our first asset (topical), and a pipeline including a long-duration retinal asset and additional SM therapeutics. We're currently raising a Series B to fund the pipeline and registrational trials.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}